Cancer News and Research

Latest Cancer News and Research

Salk receives $2 million gift to establish Endowed Chair in Vision Research

Salk receives $2 million gift to establish Endowed Chair in Vision Research

Experts caution against dangers of inflated expectations of genomic medicine

Experts caution against dangers of inflated expectations of genomic medicine

Research cuts could mean ongoing cancer deaths

Research cuts could mean ongoing cancer deaths

Canadian Cancer Society calls for legislation to ban cosmetic pesticides

Canadian Cancer Society calls for legislation to ban cosmetic pesticides

Predictive to present results on development of real-time multiplexed PCR FGFR3 assay at ASCO 2011

Predictive to present results on development of real-time multiplexed PCR FGFR3 assay at ASCO 2011

Biologist investigates CAPV-EAE population for hereditary breast and ovary cancer

Biologist investigates CAPV-EAE population for hereditary breast and ovary cancer

Watson's performance on Jeopardy! inspires 700% spike in volunteers for World Community Grid

Watson's performance on Jeopardy! inspires 700% spike in volunteers for World Community Grid

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

Scientist argues cost-effectiveness analysis should play bigger role in American health care system

Scientist argues cost-effectiveness analysis should play bigger role in American health care system

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

Phase I/II safety, efficacy data for Bellicum's BPX-101 presented at 2011 Genitourinary Cancers Symposium

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week

ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week

American Cancer Society receives AAHPM Presidential Citation Award for palliative care research

American Cancer Society receives AAHPM Presidential Citation Award for palliative care research

Canadian Cancer Society praises new, enhanced cigarette package warnings

Canadian Cancer Society praises new, enhanced cigarette package warnings

New research: Incidence of PE after knee arthroscopy is 0.028%

New research: Incidence of PE after knee arthroscopy is 0.028%

GIBH, Saint Louis University form global research partnership to combat malaria

GIBH, Saint Louis University form global research partnership to combat malaria

ASU, CGU enter agreement to establish international Biosignatures Center

ASU, CGU enter agreement to establish international Biosignatures Center

Doctor explores link between lack of oxygen and inflammation in patients undergoing surgery

Doctor explores link between lack of oxygen and inflammation in patients undergoing surgery

China Medical Technologies third quarter revenues increase 30.0% to RMB223.9 million ($33.9M)

China Medical Technologies third quarter revenues increase 30.0% to RMB223.9 million ($33.9M)

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.